Next Article in Journal
Inhibition of Corneal Neovascularization with the Combination of Bevacizumab and Plasmid Pigment Epithelium-Derived Factor-Synthetic Amphiphile INTeraction-18 (p-PEDF-SAINT-18) Vector in a Rat Corneal Experimental Angiogenesis Model
Next Article in Special Issue
HDAC6 and Ovarian Cancer
Previous Article in Journal
DNA Self-Assembly: From Chirality to Evolution
Previous Article in Special Issue
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2013, 14(4), 8271-8290;

Ovarian Cancer: Can Proteomics Give New Insights for Therapy and Diagnosis?

Department of Oncology & Haematology, University of Modena and Reggio Emilia, Modena 41125, Italy
ProteoWork Lab, the Department of Biomedical Sciences, University of Modena and Reggio Emilia, Modena 41125, Italy
Author to whom correspondence should be addressed.
Received: 1 February 2013 / Revised: 11 March 2013 / Accepted: 2 April 2013 / Published: 15 April 2013
(This article belongs to the Special Issue Genes and Pathways in the Pathogenesis of Ovarian Cancer)
Full-Text   |   PDF [668 KB, uploaded 19 June 2014]   |  


The study of the ovarian proteomic profile represents a new frontier in ovarian cancer research, since this approach is able to enlighten the wide variety of post-translational events (such as glycosylation and phosphorylation). Due to the possibility of analyzing thousands of proteins, which could be simultaneously altered, comparative proteomics represent a promising model of possible biomarker discovery for ovarian cancer detection and monitoring. Moreover, defining signaling pathways in ovarian cancer cells through proteomic analysis offers the opportunity to design novel drugs and to optimize the use of molecularly targeted agents against crucial and biologically active pathways. Proteomic techniques provide more information about different histological types of ovarian cancer, cell growth and progression, genes related to tumor microenvironment and specific molecular targets predictive of response to chemotherapy than sequencing or microarrays. Estimates of specificity with proteomics are less consistent, but suggest a new role for combinations of biomarkers in early ovarian cancer diagnosis, such as the OVA1 test. Finally, the definition of the proteomic profiles in ovarian cancer would be accurate and effective in identifying which pathways are differentially altered, defining the most effective therapeutic regimen and eventually improving health outcomes. View Full-Text
Keywords: proteomic; ovarian cancer; biomarker; therapy; OVA1 proteomic; ovarian cancer; biomarker; therapy; OVA1

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Toss, A.; De Matteis, E.; Rossi, E.; Casa, L.D.; Iannone, A.; Federico, M.; Cortesi, L. Ovarian Cancer: Can Proteomics Give New Insights for Therapy and Diagnosis? Int. J. Mol. Sci. 2013, 14, 8271-8290.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top